Chest CT helps in prediction of pneumonia in COVID-19
A recent study published in the Journal of Cardiothoracic and Vascular Anesthesia, has reported the effective use of non-invasive positive pressure ventilation (NPPV) in COVID-19 pneumonia patients. Luca Arcari, Covid-Cardiology Unit, Madre Giuseppina Vannini Hospital, Rome, Italy, and colleagues found that a semi-quantitative chest CT analysis at hospital admission may accurately identify people who respond poorly to NPPV.
Coronavirus disease-19 (COVID-19) is a respiratory tract infection having a significant rate of respiratory insufficiency, mortality, hospitalization need. NPPV is an emerging efficient tool for the treatment of Coronavirus disease-19 (COVID-19) pneumonia. However, the factors that influence the failure of NPPV are still elusive. Arcari and the team aimed to investigate the relationships between semiquantitative chest computed tomography (CT) scoring and NPPV failure and mortality in patients with COVID-19 in an observational study.
For more details, check out the full story on the link below:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.